Sponsor Pipeline

BrightPath Biotherapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07667868 A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of… Relapsed/Refractory Multiple Myeloma (RRMM) Not Yet Recruiting
Disease Areas
Multiple Myeloma (1)
Get alerts when BrightPath Biotherapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free